These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1547360)

  • 21. A comparative study of the in vitro permeation of ibuprofen in mammalian skin, the PAMPA model and silicone membrane.
    Luo L; Patel A; Sinko B; Bell M; Wibawa J; Hadgraft J; Lane ME
    Int J Pharm; 2016 May; 505(1-2):14-9. PubMed ID: 27025294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of drug permeation through human skin.
    Chandrasekaran SK; Bayne W; Shaw JE
    J Pharm Sci; 1978 Oct; 67(10):1370-4. PubMed ID: 702282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative in vitro study of transdermal absorption of antiemetics.
    Calpena AC; Blanes C; Moreno J; Obach R; Domenech J
    J Pharm Sci; 1994 Jan; 83(1):29-33. PubMed ID: 8138905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 17beta-estradiol matrixpatch removal and reapplication in postmenopausal women: theoretical predictions with an oscillating diffusion coefficient model.
    Rohr UD; Saeger-Lorenz K
    J Pharm Sci; 2002 Mar; 91(3):822-44. PubMed ID: 11920768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of finite dose absorption through skin 2: volatile compounds.
    Kasting GB; Miller MA
    J Pharm Sci; 2006 Feb; 95(2):268-80. PubMed ID: 16381026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Numerical solution of non-linear dual-phase-lag bioheat transfer equation within skin tissues.
    Kumar D; Kumar P; Rai KN
    Math Biosci; 2017 Nov; 293():56-63. PubMed ID: 28859910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mathematical models for dermal drug absorption.
    Selzer D; Neumann D; Schaefer UF
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1567-83. PubMed ID: 26166490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of Human Pharmacokinetic Profile After Transdermal Drug Application Using Excised Human Skin.
    Yamamoto S; Karashima M; Arai Y; Tohyama K; Amano N
    J Pharm Sci; 2017 Sep; 106(9):2787-2794. PubMed ID: 28315690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PBPK modeling of the percutaneous absorption of perchloroethylene from a soil matrix in rats and humans.
    Poet TS; Weitz KK; Gies RA; Edwards JA; Thrall KD; Corley RA; Tanojo H; Hui X; Maibach HI; Wester RC
    Toxicol Sci; 2002 May; 67(1):17-31. PubMed ID: 11961212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of penetrant and vehicle mixture properties on transdermal permeability using a mixed effect pharmacokinetic model of ex vivo porcine skin.
    Chittenden JT; Riviere JE
    Biopharm Drug Dispos; 2016 Oct; 37(7):387-396. PubMed ID: 27246159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On mathematical modeling of dermal and transdermal drug delivery.
    Manitz R; Lucht W; Strehmel K; Weiner R; Neubert R
    J Pharm Sci; 1998 Jul; 87(7):873-9. PubMed ID: 9649357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of drug penetration through skin considering donor concentration decrease.
    Hashida M; Okamoto H; Sezaki H
    J Pharmacobiodyn; 1988 Sep; 11(9):636-44. PubMed ID: 3216285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simplified approach for estimating skin permeation parameters from in vitro finite dose absorption studies.
    Lehman PA
    J Pharm Sci; 2014 Dec; 103(12):4048-4057. PubMed ID: 25324199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the predicted time-concentration profile of serum tulobuterol in human after transdermal application.
    Nakamura A; Mori D; Tojo K
    Chem Pharm Bull (Tokyo); 2012; 60(3):300-5. PubMed ID: 22382408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of pH and dose on nasal absorption of scopolamine hydrobromide in human subjects.
    Ahmed S; Sileno AP; deMeireles JC; Dua R; Pimplaskar HK; Xia WJ; Marinaro J; Langenback E; Matos FJ; Putcha L; Romeo VD; Behl CR
    Pharm Res; 2000 Aug; 17(8):974-7. PubMed ID: 11028944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The transient dermal exposure II: post-exposure absorption and evaporation of volatile compounds.
    Frasch HF; Bunge AL
    J Pharm Sci; 2015 Apr; 104(4):1499-507. PubMed ID: 25611182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug Delivery and Transport into the Central Circulation: An Example of Zero-Order In vivo Absorption of Rotigotine from a Transdermal Patch Formulation.
    Cawello W; Braun M; Andreas JO
    Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):475-481. PubMed ID: 29332198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reconstructed skin equivalents for assessing percutaneous drug absorption from pharmaceutical formulations.
    Zghoul N; Fuchs R; Lehr CM; Schaefer UF
    ALTEX; 2001; 18(2):103-6. PubMed ID: 11378682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lecithin organogel as matrix for transdermal transport of drugs.
    Willimann H; Walde P; Luisi PL; Gazzaniga A; Stroppolo F
    J Pharm Sci; 1992 Sep; 81(9):871-4. PubMed ID: 1432631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A biophysically based dermatopharmacokinetic compartment model for quantifying percutaneous penetration and absorption of topically applied agents. I. Theory.
    Williams PL; Riviere JE
    J Pharm Sci; 1995 May; 84(5):599-608. PubMed ID: 7658351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.